Health care quality

FDA Agrees with Galmed's Plan to use Aramchol Meglumine in the Randomized Double-Blind Placebo-Controlled Part of the Phase 3 ARMOR study

Retrieved on: 
Monday, August 2, 2021

Aramchol meglumine contains the same active pharmaceutical ingredient (API) called Aramchol.

Key Points: 
  • Aramchol meglumine contains the same active pharmaceutical ingredient (API) called Aramchol.
  • Exposure with once daily (QD) 383mg Aramchol meglumine oral dosage corresponds to that obtained with the existing twice daily (BID) 300mg Aramchol free acid form which is currently being evaluated in the Phase 3 ARMOR study.
  • This allows future development of the QD regimen with a potential improvement in convenience and adherence".
  • Our lead compound, Aramchol, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.

Treatment.com unveils a new medical library to create the future of AI healthcare

Retrieved on: 
Thursday, July 29, 2021

Treatment or The Company (CSE: TRUE), a healthcare AI technology company, announces the completion of the worlds most advanced medical database known as the Global Library of Medicine (GLM), creating a new category of tools in healthcare delivery.

Key Points: 
  • Treatment or The Company (CSE: TRUE), a healthcare AI technology company, announces the completion of the worlds most advanced medical database known as the Global Library of Medicine (GLM), creating a new category of tools in healthcare delivery.
  • This medical library is the foundation of Treatment.coms AI system that can assess patients and will be integrated into products that offer improved patient safety, cost of care, prevention, and overall healthcare outcomes.
  • Treatment.com has pioneered a new approach to building a medical library which provides individually tailored and intelligently processed knowledge, as opposed to the general data that most medical databases run from.
  • The multi-layered, multi-modular design of this extensive platform provides a medical value exchange to consumers, clinicians, and commercial users.

United States Healthcare Consumerism Growth Opportunities: Analyzing SDOH Data to Improve Patient Outcomes and Empower Consumers - ResearchAndMarkets.com

Retrieved on: 
Friday, July 30, 2021

The "United States Healthcare Consumerism Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Healthcare Consumerism Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • This research service examines the future of healthcare consumerism in the United States in terms of changing patient demographics and demands, technological advancements, digital health, shift in consumer behavior to non-traditional healthcare settings, and innovative healthcare business models.
  • Healthcare consumerism is on the rise as individuals become more engaged in making health-related decisions and assert control over their medical and wellness care.
  • Healthcare consumerism forces traditional healthcare participants to develop new care models to compete successfully in the consumer-to-business healthcare marketplace.

WellSky® to Acquire Healthify to Enhance Social Services Care Coordination Across the Continuum

Retrieved on: 
Thursday, July 29, 2021

Seamless coordination between providers, community-based organizations, and payers is the key to delivering value-based care at scale.

Key Points: 
  • Seamless coordination between providers, community-based organizations, and payers is the key to delivering value-based care at scale.
  • Together, WellSky and Healthify will connect providers across and within communities to identify social needs, search for social services, and coordinate care with an accountable network of community partners to improve outcomes and remove social barriers to health and wellness.
  • We have a longstanding commitment to investing in care coordination and whole-person care.
  • Our next-generation software, analytics, and services power better outcomes and lower costs for stakeholders across the health and community care continuum.

Medical Device and Pharmaceutical Industries Can Leverage New GS1 US Guideline for Sharing Vital Data

Retrieved on: 
Thursday, July 29, 2021

EWING, N.J., July 29, 2021 /PRNewswire/ -- GS1 US has published a new guideline, " Best Practice Guide for Sharing Vital Attributes in Healthcare ," to help healthcare trading partners share data about medical devices or pharmaceutical products.

Key Points: 
  • EWING, N.J., July 29, 2021 /PRNewswire/ -- GS1 US has published a new guideline, " Best Practice Guide for Sharing Vital Attributes in Healthcare ," to help healthcare trading partners share data about medical devices or pharmaceutical products.
  • The guideline is a resource for healthcare professionals charged with master data management, procurement, regulatory compliance and data governance.
  • This guideline also covers data recommendations for the U.S. Food and Drug Administration (FDA) Drug Supply Chain Security Act (DSCSA) enabling pharmaceutical traceability and Unique Device Identification Rule (UDI) requirements for medical device traceability.
  • For more information about GS1 US, the guideline and additional data quality healthcare resources, visit www.gs1us.org.

New Report Outlines Role of Social Determinants in Americans' Health

Retrieved on: 
Thursday, July 29, 2021

WASHINGTON, D.C., July 29, 2021 /PRNewswire/ --America's chronic disease and health disparities crisis require policy interventions targeting structural racism and the social determinants of health, concludes a report released today by Trust for America's Health.

Key Points: 
  • WASHINGTON, D.C., July 29, 2021 /PRNewswire/ --America's chronic disease and health disparities crisis require policy interventions targeting structural racism and the social determinants of health, concludes a report released today by Trust for America's Health.
  • "The COVID-19 pandemic put a spotlight on the role that social and economic conditions play in health and gives policymakers an opportunity to build an improved social supports and public health system," said J. Nadine Gracia, MD, MSCE, President and CEO of Trust for America's Health.
  • Building healthy and thriving communities and advancing health equity require improving the social and economic conditions that shape health.
  • The social determinants of health are factors beyond traditional healthcare that significantly impact health including where you are born, live, work, play, go to school, and age.

Reliq Health Technologies, Inc. Provides Corporate Update and Overview of Expanded CMS Coverage for Remote Patient Monitoring for 2022

Retrieved on: 
Wednesday, July 28, 2021

In its recently released proposed 2022 Physician Fee Schedule, CMS introduced 5 new billing codes for an expanded form of Remote Patient Monitoring (RPM) called Remote Therapeutic Monitoring (RTM).

Key Points: 
  • In its recently released proposed 2022 Physician Fee Schedule, CMS introduced 5 new billing codes for an expanded form of Remote Patient Monitoring (RPM) called Remote Therapeutic Monitoring (RTM).
  • This significantly expands the number of potential clients for Reliq as well as the size of the eligible patient population.
  • iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.
  • Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.

Quipt Home Medical to Participate at the 41st Annual Canaccord Growth Conference on August 10th - 12th

Retrieved on: 
Wednesday, July 28, 2021

The live webcast of the presentation will be available by visiting the investors' section of the company's website at www.quipthomemedical.com .

Key Points: 
  • The live webcast of the presentation will be available by visiting the investors' section of the company's website at www.quipthomemedical.com .
  • The webcast will also be available for replay on the company's website following the event.
  • The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market.
  • The Companys organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patients services and making life easier for the patient.

Kit Check Expands Clinical Team with Addition of Healthcare Industry Veterans Jennifer Splawski, Pharm.D., M.S., BCPS and Lauren Forni, Pharm.D.

Retrieved on: 
Wednesday, July 28, 2021

We are thrilled to welcome Jennifer and Lauren to our clinical team, said Doug Zurawski, Pharm.D., SVP of Clinical Strategy at Kit Check.

Key Points: 
  • We are thrilled to welcome Jennifer and Lauren to our clinical team, said Doug Zurawski, Pharm.D., SVP of Clinical Strategy at Kit Check.
  • To date, our more than 700 U.S. and Canadian hospital partners have adopted Kit Check solutions to solve the most challenging of healthcare problems.
  • Kit Check Solutions help providers save time managing inventory, prevent diversion at their facilities, save money on medication spend, and ensure patient safety.
  • More information about Kit Check and our software solutions can be found at kitcheck.com .

Dr. Saeed Khan Predicts the Transition to a New System for Primary Care

Retrieved on: 
Tuesday, July 27, 2021

With all his years of experience, he believes the future of Patient Primary care is shifting from its current model to a more Value-based system.

Key Points: 
  • With all his years of experience, he believes the future of Patient Primary care is shifting from its current model to a more Value-based system.
  • In the realm of Patient Primary Care, the current Volume-based model of care and procedure provided by various disciplines is being replaced by a new Population-based model.
  • Dr. Saeed Khan has noticed this trend and created a roadmap for a transition to a value-based system in Primary Care.
  • These changes are measures Dr. Khan believes will create a more comprehensive and efficient primary care system for both patients and providers.